Skip to content

Rehabilitation for humeral fractures in working ages

Task-oriented exercises improve disability of working adults with surgically treated proximal humeral fractures: a randomized controlled trial with one-year follow-up

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17996552
Enrollment
70
Registered
2019-12-16
Start date
2012-06-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proximal humeral fracture, following surgery Injury, Occupational Diseases, Poisoning Fracture of upper end of humerus

Interventions

Experimental group. Task-oriented exercises and occupational therapy. Control group. Passive humeral and upper limb mobilisation, strengthening, muscle segmentary stretching, and

Sponsors

Università degli Studi di Cagliari
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects undergoing surgical treatment of PHFs classified as Arbeitsgemeinschaft Osteosynthese (AO) Foundation for the Study of Internal Fixation type 11 (2) 2. A good understanding of Italian 3. Working age (20-65 years old)

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment (Mini-Mental State Examination Score of<24), unstable cardiovascular and pulmonary diseases, and systemic or neuromuscular diseases, ruled out by means of case histories and imaging 2. Subjects with isolated tuberculum majus fracture (AO 11, A1), or fractures with involvement of the glenoid cavity, double fractures or injury of the plexus or the axillary nerve 3. Subjects who had workers’ compensation

Design outcomes

Primary

MeasureTime frame
Disability assessed using the validated Italian version of the self-reported Disability Arm Shoulder Hand questionnaire before treatment, at the end (12 weeks) and at follow-up (one year after the end of treatment).

Secondary

MeasureTime frame
1. Pain intensity assessed using an 11-point numerical rating scale at baseline, 12 weeks and 12 months 2. Quality of life assessed using the Italian version of the self-report Short-Form Health Survey (SF-36) at baseline, 12 weeks and 12 months 3. Patient-rated efficacy of treatment assessed using the Global Perceived Effect scale (GPE) at end of treatment

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026